Tenderwize
Back to tender search

Open-House Biologics Discount Agreements 2025-03 - Interferon beta-1a (Avonex)

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2027 · 253 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-03 - Interferon beta-1a (Fertigarzneimittelbezeichnung: Avonex(R))

60/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume information available, making it difficult to assess revenue potential.

Discount agreements may offer low margins; terms are non-negotiable.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of discount agreements for Interferon beta-1a (Avonex) with participating health insurers under open-house terms.
Show full summary

Open-House procedure for discount agreements on Interferon beta-1a (Avonex) with Techniker Krankenkasse and other German health insurers. The procedure is open throughout the contract period (until April 2027) and any eligible pharmaceutical entrepreneur can join. No estimated value or award criteria are provided.

Risks

No estimated value or volume information available, making it difficult to assess revenue potential.

Discount agreements may offer low margins; terms are non-negotiable.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4 Abs.18 AMG for the offered drug.
  • Must have a valid marketing authorization for the drug in Germany, EU, or EEA.

Eligibility

  • Must submit self-declaration of eligibility and reliability.

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Biologics Discount Agreements 2025-03 - Interferon beta-1a (Avonex)

Conclusion of discount agreements under §130a Abs.8 SGB V for the active substance Interferon beta-1a (Avonex). Open to all qualified pharmaceutical entrepreneurs.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Deadline

Deadline Apr 29, 2027

Procurement Details

Publication date
16 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
170072-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24